-
1 week ago | 
interventionalnews.com | Eva Malpass
Maede Rouzbahani (Tehran University of Medical Sciences, Tehran, Iran) spotlights current innovations in stem cell therapy in interventional radiology (IR) and its potential within precision medicine. Stem cell therapy has emerged as a transformative approach in IR, focusing on targeted treatments for various organ systems and ischaemic conditions.
-
1 week ago | 
interventionalnews.com | Eva Malpass
In an interview with Interventional News, John Kaufman—Frederick S Keller chair of interventional radiology at Oregon Health and Science University, in Oregon, USA, president-elect of the American Board of Radiology (ABR) board of governors, and chief medical officer for Cook Medical—looked back to see ahead, addressing what is next for device development in the interventional arena.
-
2 weeks ago | 
cardiovascularnews.com | Eva Malpass
A STRIKE-PE interim analysis of clinical outcomes of acute pulmonary embolism (PE) patients with or without syncope—an indicator of compromised cardiac output and so increased short-term mortality—has found that patients with syncope who had a higher right/left ventricle (RV/LV) ratio at baseline were restored to a condition similar to patients without syncope following treatment with the Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device.
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
What computational advancements are set to transform interventional radiology (IR)? Interventional radiologist, Judy Wawira Gichoya (Emory University, Atlanta, USA) weighs in, providing a realistic outlook on developments so far. The enthusiasm of interventional radiologists for new devices that have enhanced our clinical work reveals a notable gap when considering artificial intelligence (AI) as a significant component of our toolkit.
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
Recently presented at the Society of Interventional Radiology (SIR) annual scientific meeting (29 March–2 April, Nashville, USA), data from the Jet Enhanced Thrombectomy intervention Hydrodynamic Thrombectomy System (JETi; Abbott) registry has demonstrated the device’s effectiveness having surpassed prespecified safety and efficacy thresholds for the removal of thrombus in lower extremity deep vein thrombosis (DVT).
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
Twelve-month results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial show a statistically significant improvement in target lesion primary patency (TLPP) with the Wrapsody (Merit Medical) cell-impermeable endoprosthesis (CIE) when compared to percutaneous transluminal angioplasty (PTA).
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
How can it be that this specialty society, so associated with concepts of ‘newness’, is old? We know that in 1974 a group of ‘gadgeteers’ (credit to Mike Dake for the term), dressed in plaid bellbottoms, convened in Key Largo in Florida, USA to talk geek. They munched on that year’s new snack called Skittles, and organised their thoughts and schedules with the new-fangled sticky, but not so sticky, Post-it notes.
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
Resorbable microspheres are making waves in musculoskeletal (MSK) embolization, challenging the use of permanent embolics. As clinical evidence supporting their safety and efficacy accelerates, these agents could reshape treatment strategies— offering effective pain relief while reducing long-term risks. In an interview with Interventional News, Ziv Haskal (University of Virginia, Charlottesville, USA) gives pragmatic shape to the emerging future of resorbable microspheres in MSK embolization.
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
In a subgroup analysis of the STRIKE-PE study regarding patients treated with the latest iteration of Penumbra’s 16Fr Lighting Flash computer-assisted vacuum thrombectomy (CAVT) device, Brian J Schiro (Miami Cardiac & Vascular Institute, Miami, USA) reported improved haemodynamic markers, right/left ventricle (RV/LV) ratio, dyspnoea, and overall, a “highly” improved device use time of 25.5 minutes.
-
2 weeks ago | 
interventionalnews.com | Eva Malpass
A STRIKE-PE interim analysis of clinical outcomes of acute pulmonary embolism (PE) patients with or without syncope—an indicator of compromised cardiac output and so increased short-term mortality—has found that patients with syncope who had a higher right/left ventricle (RV/LV) ratio at baseline were restored to a condition similar to patients without syncope following treatment with the Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device.
